National Bank of Canada’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
National Bank of Canada's NEO Position: Q1 2026 in Review
National Bank of Canada increased its NeoGenomics (NEO) stake by 162% in Q1 2026, buying an estimated $8.11K and bringing the position to 1,246 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2357.
National Bank of Canada first reported a position in NEO in Q4 2021 and has held it in 18 quarters since. The position peaked at $126K in Q4 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- National Bank of Canada held 1,246 shares of NeoGenomics worth $9.24K as of Q1 2026.
- National Bank of Canada bought 771 NeoGenomics shares in Q1 2026, an estimated $8.11K.
- NeoGenomics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2357 holding.
- National Bank of Canada first reported a position in NeoGenomics in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's NeoGenomics position peaked at $126K in Q4 2021.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.